GSEA suggested that CENPN could be enriched in the p53 pathway, and western blot analysis showed that p53 expression increased with CENPN knockdown, so we inferred that CENPN interferes with DNA damage by inhibiting p53 in HCC (Fig. 8G). This evidence concerns the gene TP53 and hepatocellular carcinoma.